VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular envelo... Read more
Org chart
Collapse
Board & advisors
Teams
This company has no teams yet
Offices
This company has no offices yet
